Company Filing History:
Years Active: 2016-2024
Title: John Fritiof Pontén: Innovator in Pharmaceutical Chemistry
Introduction
John Fritiof Pontén is a notable inventor based in Cheshire, GB, recognized for his significant contributions to pharmaceutical chemistry. With a total of 15 patents to his name, he has made strides in developing innovative compounds that address critical health issues.
Latest Patents
Pontén's latest patents include compounds such as certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides, which serve as dipeptidyl peptidase 1 inhibitors. These compounds are particularly relevant in treating and preventing respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). The patents detail their utility in therapy, the pharmaceutical compositions containing them, and the processes for preparing such compounds.
Career Highlights
Pontén has established a successful career at AstraZeneca AB, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also had a broader impact on public health.
Collaborations
Throughout his career, Pontén has collaborated with esteemed colleagues such as Stephen Connolly and Steven Swallow. These partnerships have fostered innovation and have been crucial in the development of his patented compounds.
Conclusion
John Fritiof Pontén's work exemplifies the importance of innovation in the pharmaceutical industry. His contributions continue to pave the way for advancements in treatments for respiratory diseases, showcasing the vital role of inventors in improving health outcomes.